ReviewCancer gene therapy2003
Cancer gene therapy: an awkward adolescence.
Review in Cancer gene therapy, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Harnessing State-of-the-Art Gene Therapy to Transform Oral Cancer Treatment.Biochemical genetics · 2026Review
- Synergetic Thermal Therapy for Cancer: State-of-the-Art and the Future.Bioengineering (Basel, Switzerland) · 2022Review
- Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery.Advanced materials (Deerfield Beach, Fla.) · 2020Review
- Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity.Human vaccines & immunotherapeutics · 2017Review
- Demonstration of Tightly Radiation-Controlled Molecular Switch Based on CArG Repeats by In Vivo Molecular Imaging.Molecular imaging and biology · 2015Article
- Downregulation of ABCE1 via siRNA affects the sensitivity of A549 cells against chemotherapeutic agents.Medical oncology (Northwood, London, England) · 2015Article
- A Drosophila ABC transporter regulates lifespan.PLoS genetics · 2014Article
- Pulsed focused ultrasound exposures enhance locally administered gene therapy in a murine solid tumor model.The Journal of the Acoustical Society of America · 2013Article
- Gene therapy, early promises, subsequent problems, and recent breakthroughs.Advanced pharmaceutical bulletin · 2013Article
- Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation.The Journal of clinical investigation · 2011Article
- A novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF.Journal of cellular and molecular medicine · 2010Article
- The current state of head and neck cancer gene therapy.Human gene therapy · 2009Review
- Exploiting the tumor microenvironment in the development of targeted cancer gene therapy.Cancer gene therapy · 2009Article
- Ultrasound mediated delivery of drugs and genes to solid tumors.Advanced drug delivery reviews · 2008Review
- HIV vector-mediated targeted suicide gene therapy for adult T-cell leukemia.Gene therapy · 2007Article
- Incorporation of biologic therapies in the management of gastroesophageal cancers.Gastrointestinal cancer research : GCR · 2007Article
- Persistent mismatch repair deficiency following targeted correction of hMLH1.Cancer gene therapy · 2007Article
- Gene therapy for malignant mesothelioma: beyond the infant years.Cancer gene therapy · 2006Review
- SV40 Pseudovirion gene delivery of a toxin to treat human adenocarcinomas in mice.Cancer gene therapy · 2006Article
- Rhodamine-RCA in vivo labeling guided laser capture microdissection of cancer functional angiogenic vessels in a murine squamous cell carcinoma mouse model.Molecular cancer · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
At the Eleventh International Conference on Gene Therapy of Cancer (December 12-14, 2002, San Diego, CA) progress on using gene transfer technology to treat cancer was presented. Although there is as yet no cancer gene therapy being marketed, considerable progress has been made in defining likely strategies and likely targets for gene therapy of cancer. These strategies, including viral and non-viral delivery systems, and potential targets in cancer cells linked to our developing knowledge of cancer cell biology, are reviewed in this paper. Use of gene therapy to sensitize tumors to radiation and chemotherapy is one promising area of investigation. Some of the ancillary benefits of research on cancer gene therapy, including the development of public-private partnerships, recruitment of laboratory scientists into clinical research, and credentialing of potential cancer cell targets for therapies other than gene therapy, are noted.
Indexed as
Identifiers
12833130What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.